Breast Cancer 101

A Guide to Breast Cancer by Susan G. Komen

Clinical Trials Overview

Transcript

Over the past 40 years, clinical trials have brought many improvements to breast cancer treatment and care. They’re vital to finding effective treatment options for cancer. Clinical trials test the safety and benefits of new treatments and new combinations or doses of drugs that are already used to treat breast cancer. Clinical trials also investigate ways to manage side effects and develop other parts of breast cancer care, meaning they may test new tools, devices or methods to assess risk, or even prevent, screen for, or diagnose breast cancer.

There are two types of clinical trials – observational and interventional.

In an observational study, participants are not assigned to an intervention – they’re only observed, and researchers measure the outcomes. These types of clinical studies are often used to identify cancer risk factors or behaviors among different populations or to identify quality of life topics that are important to survivors or those living with breast cancer.

On the other hand, in an interventional study, a participant is assigned to a group that receives one or more interventions, such as a new drug, device, procedure or diagnostic test, to assess their safety and efficacy. One example of an interventional study is the recent phase 3 PATINA clinical trial, which showed the benefit of treating some hormone receptor-positive, HER2-positive, locally advanced or metastatic breast cancers with hormone therapy and HER2-targeted therapy, trastuzumab, with or without pertuzumab, in combination with a CDK4/6 inhibitor, palbociclib. This drug combination was approved by the U.S. Food and Drug Administration, or the FDA, and is now part of the standard of care. Before this trial, palbociclib was only used to treat some hormone-receptor positive, HER2-negative breast cancers, but can now be used in some breast cancers that are HER2-positive.

Findings from large, randomized clinical trials like PATINA are viewed as the best evidence for developing treatment guidelines that direct breast cancer care.

Did you know there are four main phases of treatment-related clinical trials? Phase 1 trials focus mainly on drug safety. They look at whether a new treatment is safe and help find the best dose to use. Phase 2 trials investigate whether a drug or other therapy is an effective treatment for a certain type of cancer, such as breast cancer. Phase 3 trials examine how well a new treatment works compared to the current standard of care. Phase 4 trials look at long-term side effects or answer new questions about a treatment after it has been approved by the FDA.

One of the benefits of clinical trials is getting the chance to try a new treatment and possibly benefit from it. If researchers discover that a new therapy is better than the current standard treatment, that knowledge will help others in the future, providing added benefit. New therapies may also lead to more research and more advances in care.

It’s important to know that all trials have guidelines for who can participate. These guidelines are called eligibility criteria. They may include things such as the type and stage of breast cancer, past treatments and if a person has other medical conditions. Based on the eligibility criteria, you may not be eligible for a trial, or there may not be one currently enrolling that’s right for you.

The trial location is another consideration. Clinical trials take place across the country and around the world, including hospitals, clinics and research centers. Some may be done in one or only a few places, while others are done in many places. So, where you live may be a factor in choosing to join a clinical trial. There may not be a clinical trial that’s right for you in your area. You may have to travel to join one.

Extra visits, tests or scans are other things to consider. Clinical trials often require more blood tests and imaging tests, such as X-rays or other scans, than standard treatment alone. This means you’ll have extra visits to a medical center for these tests, which can lead to additional costs for things like travel or parking.

When thinking about your financial situation, it may help to know that the cost of the new treatment or test is usually covered by the clinical trial, and other out-of-pocket costs are often the same as those for standard treatment. If the cost of the drug therapy is covered by the clinical trial, out-of-pocket costs may be lower for someone enrolled in the clinical trial.

Before enrolling in a clinical trial, talk with your insurance company to find out which costs are covered and which are not. This makes sure you don’t have any unexpected costs, such as out-of-network fees. Many cancer centers have financial counselors who can discuss insurance and cost coverage with you and help you explore financial assistance that may be available for things like travel.

Lastly, side effects are something else to consider. The risks of a new treatment may not be fully understood, so there may be unexpected side effects. Your health care team will help you manage any side effects that you may have. They can also talk with you about all the benefits and possible drawbacks of joining a specific trial.

Some people may be hesitant to join a clinical trial because they worry they will get a placebo instead of a treatment that works. A placebo is an inactive substance, like a sugar pill, that may be used to compare with the drug that’s being studied.

In breast cancer clinical trials, a placebo is never used instead of standard treatment. In some cases, people may get the standard treatment plus a placebo instead of the standard treatment plus the new treatment that’s being studied. This means that even if a person does not get the new drug or therapy, their breast cancer will be treated the same as if they were not in the trial.

You can ask whether or not a study includes a placebo along with standard treatment. Your health care team will also review this information with you.

So, when can you consider joining a clinical trial?

If you’ve been diagnosed with early or locally advanced breast cancer, you may want to ask about joining a clinical trial before starting treatment. Once a standard treatment regimen has started, it may be harder to join some clinical trials.

If you have a breast cancer recurrence, which is a return of breast cancer, consider joining a clinical trial before treatment for the recurrence begins or when your health care provider is considering changing treatments.

If you’ve been diagnosed with metastatic breast cancer, you may want to ask about joining a clinical trial before starting a new treatment, when your oncologist is thinking about changing treatment or when fewer treatment options are left.

Remember, clinical trials are not only for people who are undergoing cancer treatment. If you’ve finished treatment or even if you’ve never been diagnosed with cancer, there may still be a clinical trial available to you.

If you’re interested in joining a clinical trial, ask your health care team whether any trials might be a good fit for you. Be sure to talk about the details of each study, including the benefits and risks, so that you can make a decision that’s right for you.

In addition to asking your health care team about finding a clinical trial, a number of sources have information about them. One of the most comprehensive lists of current clinical trials can be found on the National Institutes of Health website at www.clinicaltrials.gov.

Many people make clinical trials possible, including dedicated physicians, researchers and other health care professionals, as well as hospitals, medical research centers and organizations that provide funding.

But the most important people are the volunteers who take part. People who choose to join clinical trials help researchers learn more about breast cancer and improve care.

Susan G. Komen® has several online resources to help you learn more about clinical trials.

The Clinical Trials page on komen.org is a good place to start. From this page, you can access our dedicated clinical trials content in the treatment section of komen.org and our free, downloadable educational resources on the topic. For example, our Questions to Ask Your Doctor resource is a conversation starter and a valuable tool when you’re overwhelmed and unsure about what to ask your doctor. You can download and print it to take to your next doctor’s appointment, or you can save it on your computer, tablet or phone using an app such as Adobe. Plenty of space and a notes section are provided to write or type the answers to the questions.

The Clinical Trials page can also connect you to our Breast Cancer Breakthroughs video series and Spotlight on Clinical Trials blogs and podcasts, which feature the latest information on breast cancer research.

In collaboration with Komen, BreastCancerTrials.org offers a custom matching service that can help people find clinical trials that fit their needs.

Finally, if you or a loved one needs more information or resources about clinical trials, you can contact Komen’s Breast Care Helpline at 1-877 GO KOMEN (1-877-465-6636) or email clinicaltrialinfo@komen.org.

Visit komen.org to get started.

Resources